Skip to main content

Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) Investor Securities Class Action Lawsuit 11/18/2021

  • If you purchased a significant amount of shares of Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) between May 11, 2021 and October 5, 2021, and / or if you purchased any NYSE: DNA shares prior to May 2021 and continue to hold any of those shares, you have certain options and for certain investors are short and strict deadlines running. Deadline: January 17, 2022. NYSE: DNA investors should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

March 15, 2023 - A third amended complaint was filed. March 10, 2023 - The court issued an order granting in part and denying in part the motion to dismiss, leave was given to amend the complaint. July 21, 2022 - A motion was filed to dismiss the second amended consolidated complaint. July 18, 2022 - A second amended complaint was filed. May 26, 2022 - An amended complaint was filed. ...

You must register (for free) or login to view the entire case.